A Functional MRI Study on Erenumab Treatment Effects in Episodic Migraine Patients

Clinical trial NCT03977649 · COMPLETED

Trial details

NCT number: NCT03977649
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Migraine Disorders

Start date: 2019-07-30
Primary completion: 2021-07-05
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.